Product(s):
Develops the NIMBUS antimicrobial polymer system to destroy bacteria at the cellular level and the MultiStat system of matrix metalloproteinase inhibitors
Management:
Nam H. Nguyen, CFO
Gerald M. Olderman, VP-R&D
Gregory S. Schultz, VP-laboratory & clinical research
Roy D. Carr, director-medical devices business development
Quick-Med Technologies Inc.